PM360

SEPTEMBER 21, 2023

They do not have biosimilar or generic competition available in the market. Additionally, highly competitive classes, such as rapid-acting insulin and immunologics are included on the selected drug list. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

European Pharmaceutical Review

AUGUST 21, 2023

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 billion sales globally by 2029, this could offset Keytruda’s decline sales expected after its loss of exclusivity in 2028, GlobalData highlighted. trillion in the Q1 of 2023 to $3.56

Biopharma 82

Biopharma Marketing Sales Medicine 82

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. exclusions exist for orphan drug designation and biosimilar competition ).

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Every Ancillary

MAY 14, 2021

Cons: Highly competitive with new options continually emerging. That being said, the clinical laboratory market is expected to see growth of nearly 40% by 2028. Delivers real clinical value leading to more effective treatment plans. Pros: A growing market means a good chance for long-term success with each client.

Medical sales 52

Medical sales Medical Sales Insurance 52

European Pharmaceutical Review

NOVEMBER 30, 2023

NEWS: Biopharma struggling to find talent with adequate digital skills Looking onward to 2028, the Skills report predicted that, out of a total 81 percent within the cell and gene therapy industry, roles will span support services, R&D and discovery, and bioprocessing.

Manufacturing 74

Manufacturing Recruitment Medicine Biopharma 74

Spotio

APRIL 4, 2023

billion by 2028. That means competition is fierce, especially in high-growth locations. Generate leads that match the profile you’ve created. SPOTIO’s Lead Machine enables reps to prospect by 200+ different data points. Use Multiple Communication Channels How do your reps connect with leads?

Prospecting 52

Prospecting Sales pitches Sales Leads 52

Sales Talent

FEBRUARY 7, 2020

This pressure is leading to increased base salaries. It also means that employers face the most competitive, candidate-driven employment market in history. jobs by 2028 , there should be an even bigger shortfall between the number of open jobs and available workers. percent annually in the 1970s to just.4 4 percent in 2020.

Sales 52

Sales B2B Sales Recruitment Marketing 52

Clarivate

APRIL 18, 2024

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. In 2019, UnitedHealth Group CEO David Wichmann indicated a plan to make Optum a $100B business by 2028, including by partnering with health systems for administrative services such as RCM and IT.

Retail 52

Retail Healthcare Healthcare Physicians 52

Medico Reach

OCTOBER 17, 2022

million by 2028. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. Non-small cell lung cancer leads as the indication with the highest number of PROTACs in the pipeline, currently sitting at 11 preclinical candidates.

Competition 59

Competition Safety Patients Pharmaceutical 59

Medico Reach

OCTOBER 17, 2022

million by 2028. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52